Loading...
Loading...
All product recalls associated with BRAUN AMBULANCES.
Total Recalls
1000
Past Year
1000
Class I (Serious)
127
Most Recent
Jan 2026
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
Braun Industries, Inc. (Braun Ambulances) is recalling certain 2023-2026 Chief XL Type I, Express Plus Type I, Liberty Type I, RMT US Type I, and Select Chief XL Type I ambulances. The brake pedal switch may have been damaged, preventing the cruise control from disengaging when the brake is depressed. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard numbers 105, "Hydraulic and Electric Brake Systems" and 124, "Accelerator Control Systems."
GE HealthCare has become aware that the Instructions for Use within the user guide and service manual do not adequately state the required battery replacement intervals, end-of-life handling procedures, or general battery safety precautions.
GE HealthCare has become aware that the Instructions for Use within the user guide and service manual do not adequately state the required battery replacement intervals, end-of-life handling procedures, or general battery safety precautions.
GE HealthCare has become aware that the Instructions for Use within the user guide and service manual do not adequately state the required battery replacement intervals, end-of-life handling procedures, or general battery safety precautions.
GE HealthCare has become aware that the Instructions for Use within the user guide and service manual do not adequately state the required battery replacement intervals, end-of-life handling procedures, or general battery safety precautions.
GE HealthCare has become aware that the Instructions for Use within the user guide and service manual do not adequately state the required battery replacement intervals, end-of-life handling procedures, or general battery safety precautions.
GE HealthCare has become aware that the Instructions for Use within the user guide and service manual do not adequately state the required battery replacement intervals, end-of-life handling procedures, or general battery safety precautions.
Due to firm mistakenly distributing product within the U.S. without FDA premarket clearance/approval.
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
Labeling: Incorrect or Missing Lot and/or Exp Date
Labeling: Incorrect or Missing Lot and/or Exp Date
Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm.
Labeling: Incorrect or Missing Lot and/or Exp Date
The device may either fail to start up, or the transducer may start briefly and then stop, accompanied by an error light on the generator. In addition, the body of the transducer handpiece may gradually increase in temperature during clinical use.
Product may contain Listeria monocytogenes.
Lack of Assurance of Sterility:
Chrysler (FCA US, LLC) is recalling certain 2020-2025 Alfa Romeo Giulia and Alfa Romeo Stelvio vehicles. The printed circuit board and software for the rearview camera may contain defects that cause the rearview camera image not to display properly. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard (FMVSS) number 111, "Rear Visibility."
CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots.
Potential contamination with Listeria monocytogenes